ArticleOncology research2021

()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes.

Hongde Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.